Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Elanco Animal Health Incorporated (ELAN) vs Hims & Hers Health, Inc. (HIMS)

Elanco Animal Health Incorporated and Hims & Hers Health, Inc. are both Drug Manufacturers Specialty & Generic companies. Elanco Animal Health Incorporated is the larger, with a market value of $11.2B against $6.9B — 1.6× the size. Hims & Hers Health, Inc. grew revenue faster over the last twelve months: 28.0% against 12.0%. Elanco Animal Health Incorporated has the higher net margin (−3.96% vs −5.51%) and the higher return on invested capital (0.51% vs −11.4%). Across the 19 metrics below, Elanco Animal Health Incorporated leads on 13 and Hims & Hers Health, Inc. on 6.

Valuation

Metric ELAN HIMS Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 2.22 2.65 2.25
P/B 1.69 21.07 1.90
Price to free cash flow 31.22 82.23 16.54
EV/EBITDA 18.78 n/m 12.29
EV/Sales 2.89 2.85 2.56
Earnings yield (1.84%) (2.07%) (2.99%)
Free cash flow yield 3.20% 1.22% 0.00%

Profitability

Metric ELAN HIMS Drug Manufacturers Specialty & Generic median
Gross margin 55.36% 68.43% 53.94%
Operating margin 1.61% (5.99%) 0.00%
Net margin (3.96%) (5.51%) 0.00%
Free cash flow margin 7.55% 3.22% 0.00%
Return on equity (2.98%) (32.03%) (0.40%)
Return on assets (1.46%) (5.16%) (3.32%)
Return on invested capital 0.51% (11.38%) 0.00%

Growth

Metric ELAN HIMS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 11.95% 28.04% 10.01%
EPS growth (last fiscal year) (169.12%) (3.77%) —
Revenue growth, 5-year CAGR 7.59% 53.90% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELAN HIMS Drug Manufacturers Specialty & Generic median
Debt to equity 0.59 4.21 0.05
Current ratio 2.05 0.93 2.31
Net debt to EBITDA 5.00 2.43 0.85

Dividend

Metric ELAN HIMS Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ELAN HIMS Drug Manufacturers Specialty & Generic median
Market cap 11.21b 6.87b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack